Effect of white wine consumption on oxidative stress markers and homocysteine levels

Physiological Research

Volumn 56, Issue 2, 2007, Pages 203-212

  Rajdl, D ^a   Racek, J ^a   Trefil, L ^a   Siala, K ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Homocysteine; Oxidative stress; White wine

Indexed keywords

APOLIPOPROTEIN; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; PON1 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CZECH REPUBLIC; DRINKING BEHAVIOR; ENZYMOLOGY; HUMAN; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; RISK FACTOR; WINE;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEINS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; CZECH REPUBLIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; LIVER; MALE; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; WINE;

EID: 34247846243     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. AVIRAM M, FUHRMAN B: Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann N Y Acad Sci 957: 146-161, 2002.
2. BALKAN J, OZTEZCAN S, KUCUK M, CEVIKBAS U, KOCAK-TOKER N, UYSAL M: The effect of betaine treatment on triglyceride levels and oxidative stress in the liver of ethanol-treated guinea pigs. Exp Toxicol Pathol 55: 505-509, 2004.
3. BARAK AJ, BECKENHAUER HC, TUMA DJ: Methionine synthase. A possible prime site of the ethanolic lesion in liver. Alcohol 26: 65-67, 2002.
4. BASAŘOVÁ G, ČERNÁ I: Methods for polyphenol determination and their practical importance (in Czech). Kvasný průmysl 20: 121, 1974.
5. BELLÍ N, MARÍN S, SANCHIS V, RAMOS A: Review: Ochratoxin a (OTA) in wines, musts and grape juices: Occurrence, regulations and methods of analysis. Food Sci Technol Int 8: 325-335, 2002.
6. BLEICH S, BLEICH K, KROPP S, BITTERMANN HJ, DEGNER D, SPERLING W, RUTHER E, KORNHUBER J: Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French paradox? Alcohol Alcohol 36: 1891-1892, 2001.
7. CARTRON E, FOURET G, CARBONNEAU M, LAURET C, MICHEL F, MONNIER L, DESCOMPS B, LEGER CL: Red-wine beneficial long-term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine-description of two O-methylated derivatives of gallic acid in humans. Free Radic Res 37: 1021-1035, 2003.
8. CUI J, TOSAKI A, BERTELLI AAE, BERTELLI A, MAULIK N, DAS DK: Cardioprotection with white wine. Drugs Exp Clin Res 28: 1-10, 2002.
9. DE LA VEGA MJ, SANTOLARIA F, GONZALEZ-REIMERS E, ALEMAN MR, MILENA A, MARTINEZ-RIERA A, GONZALEZ-GARCIA C: High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol 25: 59-67, 2001.
10. DEMROW HS, SLANE PR, FOLTS JD: Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91: 1182-1188, 1995.
11. DI CASTELNUOVO A, ROTONDO S, IACOVIELLO L, DONATI MB, DE GAETANO G: Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105: 2836-2844, 2002.
12. DIXON JB, DIXON ME, O'BRIEN PE: Reduced plasma homocysteine in obese red wine consumers: a potential contributor to reduced cardiovascular risk status. Eur J Clin Nutr 56: 608-614, 2002.
13. FERRE N, CAMPS J, PRATS E, VILELLA E, PAUL A, FIGUERA L, JOVEN J: Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem 48: 261-268, 2002.
14. FLESCH M, SCHWARZ A, BOHM M: Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 275: H1183-H1190, 1998.
15. GANJI V, KAFAI MR: Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third national health and nutrition examination survey, 1988-1994. Am J Clin Nutr 77: 826-833, 2003.
16. GOLDBERG IJ, MOSCA L, PIANO MR, FISHER EA: AHA science advisory: wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 103: 472-475, 2001.
17. HASSELWANDER O, MCMASTER D, FOGARTY DG, MAXWELL AP, NICHOLLS DP, YOUNG IS: Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure. Clin Chem 44: 179-181, 1998.
18. JENTZSCH AM, BACHMANN H, FURST P, BIESALSKI HK: Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20: 251-256, 1996.
19. JI C, KAPLOWITZ N: Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124: 1488-14499, 2003.
20. KALOUSOVÁ M, ZIMA T, TESAŘ V, DUSILOVÁ- SULKOVÁ S, ŠKRHA J: Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579: 37-46, 2005.
21. KLATSKY AL, ARMSTRONG MA, FRIEDMAN GD: Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol 80: 416-20, 1997.
22. LANDRAULT N, POUCHERET P, RAVEL P, GASC F, CROS G, TEISSEDRE PL: Antioxidant capacities and phenolics levels of French wines from different varieties and vintages. J Agric Food Chem 49: 3341-3348, 2001.
23. LEFEVRE G, BELJEAN-LEYMARIE M, BEYERLE F, BONNEFONT-ROUSSELOT D, CRISTOL JP, THEROND P, TORREILLES J: Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances (in French). Ann Biol Clin (Paris) 56: 305-319, 1998.
24. LONN E, BOSCH J, YUSUF S, SHERIDAN P, POGUE J, ARNOLD JMO, ROSS C, ARNOLD A, SLEIGHT P, PROBSTFIELD J, DAGENAIS GR: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293: 1338-1347, 2005.
25. MACKNESS B, DURRINGTON P, MCELDUFF P, YARNELL J, AZAM N, WATT M, MACKNESS M: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107: 2775-2779, 2003.
26. MACLURE M: Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 15: 328-351, 1993.
27. MAR MH, ZEISEL SH: Betaine in wine: answer to the French paradox? Med Hypotheses 53: 383-385, 1999.
28. MAYER OJ, ŠIMON J, ROSOLOVÁ H: A population study of the influence of beer consumption on folate and homocysteine concentrations. Eur J Clin Nutr 55: 605-609, 2001.
29. MENNEN LI, DE COURCY GP, GUILLAND J, DUCROS V, ZAREBSKA M, BERTRAIS S, FAVIER A, HERCBERG S, GALAN P: Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French supplementation with antioxidant vitamins and minerals study. Am J Clin Nutr 78: 334-338, 2003.
30. MORENO-LABANDA JF, MALLAVIA R, PEREZ-FONS L, LIZAMA V, SAURA D, MICOL V: Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety. J Agric Food Chem 52: 5396-5403, 2004.
31. NG CJ, SHIH DM, HAMA SY, VILLA N, NAVAB M, REDDY ST: The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 38: 153-163, 2005.
32. OLTHOF MR, VAN VLIET T, BOELSMA E, VERHOEF P: Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 133: 4135-4138, 2003.
33. PEREZ DD, STROBEL P, FONCEA R, DIEZ MS, VASQUEZ L, URQUIAGA I, CASTILLO O, CUEVAS A, SAN MARTIN A, LEIGHTON F: Wine, diet, antioxidant defenses, and oxidative damage. Ann N Y Acad Sci 957: 136-145, 2002.
34. RAJDL D, RACEK J, TREFIL L, NOVOTNÝ Z, STOŽICKÝ F, STEINEROVÁ A, SIALA K: Markers and oxidative stress in diabetic mothers and their infants during delivery. Physiol Res 54: 429-436, 2005.
35. RACEK J, RUSNÁKOVÁ H, TREFIL L, SIALA K: The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidaemia on hyperhomocysteinemia. Physiol Res 54: 87-95, 2005.
36. RAO MN, MARMILLOT P, GONG M, PALMER DA, SEEFF LB, STRADER DB, LAKSHMAN MR: Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52: 1287-1294, 2003.
37. RIMM EB, WILLIAMS P, FOSHER K, CRIQUI M, STAMPFER MJ: Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319: 1523-1528, 1999.
38. SAIJA A, SCALESE M, LANZA M, MARZULLO D, BONINA F, CASTELLI F: Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 19: 481-486, 1995.
39. SALONEN JT: Markers of oxidative damage and antioxidant protection: assessment of LDL oxidation. Free Radic Res 33 (Suppl): S41-S46, 2000.
40. SIERKSMA A, VAN DER GAAG MS, VAN TOL A, JAMES RW, HENDRIKS HFJ: Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res 26: 1430-1435, 2002.
41. STEPHENS NG, PARSONS A, SCHOFIELD PM, KELLY F, CHEESEMAN K, MITCHINSON MJ: Randomised controlled trial of vitamin e in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347: 781-786, 1996.
42. TRUELSEN T, GRONBAEK M, SCHNOHR P, BOYSEN G: Intake of beer, wine, and spirits and risk of stroke: The Copenhagen City Heart Study. Stroke 29: 2467-2472, 1998.
43. TŘÍSKA J, VRCHOTOVÁ N, KYSELÁKOVÁ M, BALÍK J, VEVERKA J, TOTUŠEK J, LEFNEROVÁ D: The distribution of resveratrol and other phenolic compounds in the berries and stems of the red vine. In: OIV - Congress 2004. The International Organization of Vine and Wine, Vienna, Austria, 2004, pp P-4.04 (8 pages) (CD ROM).
44. TSELEPIS A, LOURIDA E, TZIMAS P, ROUSSIS I: Comparative antioxidant effectiveness of white and red wine and their phenolic extracts towards low-density lipoprotein oxidation. Food Biotechnology 19: 1-14, 2005.
45. VAN DER GAAG MS, VAN TOL A, SCHEEK LM, JAMES RW, URGERT R, SCHAAFSMA G, HENDRIKS HF: Daily moderate alcohol consumption increases serum paraoxonase activity, a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 147: 405-410, 1999.
46. VAN DER GAAG MS, UBBINK JB, SILLANAUKEE P, NIKKARI S, HENDRIKS HF: Effect of consumption of red wine, spirits, and beer on serum homocysteine. Lancet 355: 1522, 2000a.
47. VAN DER GAAG MS, VAN DEN BERG R, VAN DEN BERG H, SCHAAFSMA G, HENDRIKS HF: Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men. Eur J Clin Nutr 54: 586-591, 2000b.
48. WHELAN AP, SUTHERLAND WHF, MCCORMICK MP, YEOMAN DJ, DE JONG SA, WILLIAMS MJA: Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J 34: 224-228, 2004.
49. WITKO-SARSAT V, FRIEDLANDER M, CAPEILLERE-BLANDIN C, NGUYEN-KHOA T, NGUYEN AT, ZINGRAFF J, JUNGERS P, DESCAMPS-LATSCHA B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.
50. YAZICI C, KOSE K, CALIS M, DEMIR M, KIRNAP M, ATES F: Increased advanced oxidation protein products in Behcet's disease: a new activity marker? Br J Dermatol 151: 105-111, 2004.
51. YUSUF S, DAGENAIS G, POGUE J, BOSCH J, SLEIGHT P: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 154-160, 2000.